Search

everythinglearnresearchcommunity

for

Search:↓

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Post-COVID-19 patients are at risk for hair loss.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Kampo medicine can help treat general fatigue from long COVID.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

A woman's complete hair loss condition improved after recovering from COVID-19.

Drug repurposing speeds up development, cuts costs, and uses known safe drugs, but faces challenges like regulations and patents.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.